Skip to main content
SpringerLink
Log in

Partial EVPI feasible as part of HTA in Ireland

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • McCullagh L, et al. Examining the Feasibility and Utility of Estimating Partial Expected Value of Perfect Information (via a Nonparametric Approach) as Part of the Reimbursement Decision-Making Process in Ireland: Application to Drugs for Cancer. PharmacoEconomics : 2 Aug 2017. Available from: URL: http://dx.doi.org/10.1007/s40273-017-0552-y

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Partial EVPI feasible as part of HTA in Ireland. PharmacoEcon Outcomes News 785, 25 (2017). https://doi.org/10.1007/s40274-017-4275-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4275-2

Search

Navigation